Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in Eur J Cancer Retrieve available abstracts of 56 articles: HTML format Text format

Single Articles

January 2012
1. MILES D , Zielinski C, Martin M, Vrdoljak E, et al
   Combining capecitabine and bevacizumab in metastatic breast cancer: A comprehensive review.
   Eur J Cancer. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. BENDIFALLAH S , Defert S, Chabbert-Buffet N, Maurin N, et al
   Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: an external validation study.
   Eur J Cancer. 2012;48:30-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. CORTES J , Caralt M, Delaloge S, Cortes-Funes H, et al
   Safety of bevacizumab in metastatic breast cancer patients undergoing surgery.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. RUTGERS E , Piccart-Gebhart MJ, Bogaerts J, Delaloge S, et al
   The EORTC 10041/BIG 03-04 MINDACT trial is feasible: results of the pilot phase.
   Eur J Cancer. 2011;47:2742-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. YAN T , Yin W, Zhou Q, Zhou L, et al
   The efficacy of zoledronic acid in breast cancer adjuvant therapy: A meta-analysis of randomised controlled trials.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. WANG X , Su L, Ou Q
   Yes-associated protein promotes tumour development in luminal epithelial derived breast cancer.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
7. LIEDTKE C , Packeisen J, Hess KR, Vogt U, et al
   Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. HUY C , Schmidt ME, Vrieling A, Chang-Claude J, et al
   Physical activity in a German breast cancer patient cohort: One-year trends and characteristics associated with change in activity level.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. CURTIT E , Nouyrigat P, Dohollou N, Levy E, et al
   Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines.
   Eur J Cancer. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. RUITERKAMP J , Ernst MF
    The role of surgery in metastatic breast cancer.
    Eur J Cancer. 2011;47 Suppl 3:S6-S22.
    PubMed     Text format     Related articles   
    
    
    
    
11. CALDAS C
    Translational genomics in breast cancer.
    Eur J Cancer. 2011;47 Suppl 3:S381-2.
    PubMed     Text format     Related articles   
    
    
    
    
12. JOHNSTON SR
    The role of chemotherapy and targeted agents in patients with metastatic breast cancer.
    Eur J Cancer. 2011;47 Suppl 3:S38-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. OAKMAN C , Moretti E, Pacini G, Santarpia L, et al
    Triple negative breast cancer: a heterogeneous subgroup denned by what it is not.
    Eur J Cancer. 2011;47 Suppl 3:S370-2.
    PubMed     Text format     Related articles   
    
    
    
    
14. OTTO F
    Male breast cancer - neglected tumour.
    Eur J Cancer. 2011;47 Suppl 3:S340-1.
    PubMed     Text format     Related articles   
    
    
    
    
15. SORLIE T
    How to personalise treatment in early breast cancer.
    Eur J Cancer. 2011;47 Suppl 3:S310-1.
    PubMed     Text format     Related articles   
    
    
    
    
16. AUDISIO RA
    Breast cancer in the elderly: different treatment modalities.
    Eur J Cancer. 2011;47 Suppl 3:S286-9.
    PubMed     Text format     Related articles   
    
    
    
    
17. BODMER A , Castiglione-Gertsch M
    Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer.
    Eur J Cancer. 2011;47 Suppl 3:S28-37.
    PubMed     Text format     Related articles   
    
    
    
    
18. BUDACH W
    Radiotherapy in patients with metastatic breast cancer.
    Eur J Cancer. 2011;47 Suppl 3:S23-7.
    PubMed     Text format     Related articles   
    
    
    
    
19. AUTIER P
    Breast cancer screening.
    Eur J Cancer. 2011;47 Suppl 3:S133-46.
    PubMed     Text format     Related articles   
    
    
    
    
20. JOHNSTON SR
    Chairperson's introduction: Despite significant advances in the diagnosis and treatment of breast cancer, approximately one third of patients still develop, and subsequently die from metastatic breast disease.
    Eur J Cancer. 2011;47 Suppl 3:S4-5.
    PubMed     Text format     Related articles   
    
    
    
    
21. BAILDAM AD
    Skin-sparing mastectomy.
    Eur J Cancer. 2011;47 Suppl 3:S342-3.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
22. EICHER M , Kadmon I, Claassen S, Marquard S, et al
    Training breast care nurses throughout Europe: The EONS postbasic curriculum for breast cancer nursing.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. PARK CY , Son JY, Jin CH, Nam JS, et al
    EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. HANSEN J , Stevens RG
    Case-control study of shift-work and breast cancer risk in Danish nurses: Impact of shift systems.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. REINARTZ S , Failer S, Schuell T, Wagner U, et al
    CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
26. SHARP L , Johansson H, Landin Y, Moegelin IM, et al
    Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments - A pilot study.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. FEDELE P , Marino A, Orlando L, Schiavone P, et al
    Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. ADAMO V , Ricciardi GR, De Placido S, Colucci G, et al
    Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. PIVOT X , Schneeweiss A, Verma S, Thomssen C, et al
    Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADO.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. FAGUNDES CP , Lindgren ME, Shapiro CL, Kiecolt-Glaser JK, et al
    Child maltreatment and breast cancer survivors: Social support makes a difference for quality of life, fatigue and cancer stress.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. KOPPELMANS V , Schagen SB, Poels MM, Boogerd W, et al
    Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapy.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. CHUA TC , Saxena A, Liauw W, Chu F, et al
    Hepatic resection for metastatic breast cancer: A systematic review.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. CAMPBELL HE , Epstein D, Bloomfield D, Griffin S, et al
    The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. WOLTERS R , Regierer AC, Schwentner L, Geyer V, et al
    A comparison of international breast cancer guidelines - Do the national guidelines differ in treatment recommendations?
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. VON MINCKWITZ G , Schwedler K, Schmidt M, Barinoff J, et al
    Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. YASOJIMA H , Shimomura A, Naoi Y, Kishi K, et al
    Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. CLOUGH-GORR KM , Thwin SS, Stuck AE, Silliman RA, et al
    Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. HAN HS , Reis IM, Zhao W, Kuroi K, et al
    Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. KONG X , Moran MS, Zhang N, Haffty B, et al
    Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. ALI AM , Ueno T, Tanaka S, Takada M, et al
    Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patients.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
41. AMADORI D , Milandri C, Comella G, Saracchini S, et al
    A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. VICHAPAT V , Gillett C, Fentiman IS, Tutt A, et al
    Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. HARTMANN MC , Dwyer RM, Costello M, Potter SM, et al
    Relationship between CCL5 and transforming growth factor-beta1 (TGFbeta1) in breast cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. BARTON SR , Smith IE, Kirby AM, Ashley S, et al
    The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathy.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
45. LIN T , Ding Z, Li N, Xu J, et al
    Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kappaB suppression.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. CORSETTI V , Houssami N, Ghirardi M, Ferrari A, et al
    Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
    Eur J Cancer. 2011;47:1021-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
47. BOESEN EH , Karlsen R, Christensen J, Paaschburg B, et al
    Psychosocial group intervention for patients with primary breast cancer: A randomised trial.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SABATIER R , Jacquemier J, Bertucci F, Esterni B, et al
    Peritumoural vascular invasion: A major determinant of triple-negative breast cancer outcome.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
49. OTVOS L JR , Kovalszky I, Riolfi M, Ferla R, et al
    Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. VILLANUEVA C , Awada A, Campone M, Machiels JP, et al
    A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. LANGBALLE R , Olsen JH, Andersson M, Mellemkjaer L, et al
    Risk for second primary non-breast cancer in pre- and postmenopausal women with breast cancer not treated with chemotherapy, radiotherapy or endocrine therapy.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. REUBEN JM , Lee BN, Gao H, Cohen EN, et al
    Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44(+)CD24(lo) cancer stem cell phenotype.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
53. KIMMAN ML , Dirksen CD, Voogd AC, Falger P, et al
    Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCT.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. SCHRODER CP , de Munck L, Westermann AM, Smit WM, et al
    Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. KIMMAN ML , Dirksen CD, Voogd AC, Falger P, et al
    Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2x2 randomised controlled trial.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. ARNAUD O , Boumendjel A, Geze A, Honorat M, et al
    The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecan.
    Eur J Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: